Cargando…
Identification of Aryl Polyamines Derivatives as Anti-Trypanosoma cruzi Agents Targeting Iron Superoxide Dismutase †
Chagas disease (CD) is a tropical and potentially fatal infection caused by Trypanosoma cruzi. Although CD was limited to Latin America as a silent disease, CD has become widespread as a result of globalization. Currently, 6–8 million people are infected worldwide, and no effective treatment is avai...
Autores principales: | Martín-Escolano, Rubén, Molina-Carreño, Daniel, Martín-Escolano, Javier, Clares, Mª Paz, Galiana-Roselló, Cristina, González-García, Jorge, Cirauqui, Nuria, Llinares, José M., Rosales, María José, García-España, Enrique, Marín, Clotilde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863987/ https://www.ncbi.nlm.nih.gov/pubmed/36678771 http://dx.doi.org/10.3390/pharmaceutics15010140 |
Ejemplares similares
-
An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase
por: Olmo, Francisco, et al.
Publicado: (2015) -
An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment
por: Martín-Escolano, Javier, et al.
Publicado: (2022) -
Library of Selenocyanate and Diselenide Derivatives as In Vivo Antichagasic Compounds Targeting Trypanosoma cruzi Mitochondrion
por: Martín-Escolano, Rubén, et al.
Publicado: (2021) -
Trypanosoma cruzi iron superoxide dismutases: insights from phylogenetics to chemotherapeutic target assessment
por: Hickson, Jéssica, et al.
Publicado: (2022) -
A step forward in the development of superoxide dismutase mimetic nanozymes: the effect of the charge of the surface on antioxidant activity
por: Martínez-Camarena, Álvaro, et al.
Publicado: (2019)